The Mosaic Company
MOS
$24.48
-3.58%
The Mosaic Company is one of the world's largest producers of concentrated phosphate and potash crop nutrients, operating phosphate rock mines in Florida and Louisiana, potash mines in Saskatchewan, and a vertically integrated fertilizer distribution and retail business in Brazil through Mosaic Fertilizantes. As a commodity-scale agricultural inputs producer, Mosaic occupies a critical position in global food security infrastructure, with its competitive identity rooted in low-cost North American resource ownership and a unique exposure to Brazilian agricultural demand that pure-play peers lack. The current investor narrative is dominated by a sharp divergence between reported results and forward expectations: Q1 2026 swung to a $257.6 million net loss on compressed 7.9% gross margins, yet the stock has rallied roughly 11% over both the past one and three months as fertilizer prices firm on supply disruptions — notably the Strait of Hormuz closure that stranded a third of global fertilizer supply and disproportionately benefits North American producers with domestic inputs. Simultaneously, analysts are divided, with Freedom Broker upgrading to Buy from Sell in June 2026 while JP Morgan maintains an Underweight rating, reflecting genuine debate over whether the margin trough has passed or whether structural oversupply will persist.…
MOS
The Mosaic Company
$24.48
Investment Opinion: Should I buy MOS Today?
The synthesized recommendation is a Hold with a speculative bias, anchored by the analyst consensus 'buy' rating (mean 2.45) and an average target price of $26.77, implying 6.3% upside from $25.19. The core thesis is that Mosaic is a deep-value cyclical play on fertilizer supply disruptions, but the Q1 2026 net loss of $257.6 million and negative free cash flow of -$489.3 million create near-term uncertainty that warrants caution. The stock's 0.63x price-to-book and 0.63x price-to-sales ratios are at historic lows, suggesting the market has priced in a prolonged downcycle, but a recovery is not yet confirmed.
Supporting evidence for a Hold includes the 14.4% year-over-year revenue growth in Q1 2026 to $2.998 billion, which shows demand resilience despite margin compression. The EV/EBITDA of 4.84x is well below the broader market and typical sector levels, implying deep value if EBITDA normalizes; for context, the agricultural inputs industry often trades at 8-10x EV/EBITDA. The dividend yield of 3.67% provides income, though the 51.9% payout ratio raises sustainability concerns. Analyst estimates project a dramatic recovery, with forward EPS of $2.82 versus trailing EPS of $0.07, and the high target of $35.00 implies 39% upside if margin recovery materializes. The recent 11.5% monthly gain and 12.5 percentage point relative strength versus the S&P 500 suggest that idiosyncratic catalysts, such as the Hormuz closure, are driving the stock.
The biggest risks that could invalidate the thesis are a failure of fertilizer prices to sustain recent gains, a dividend cut due to negative free cash flow, and a breakdown below the $19.80 support level. This Hold would upgrade to Buy if gross margins recover above 15% and free cash flow turns positive, or if the stock pulls back to the $20-$21 range with improving fundamentals. It would downgrade to Sell if revenue growth decelerates below 5%, if the dividend is cut, or if the stock breaks below $19.80. Relative to its own history and peers, Mosaic appears undervalued on asset-based metrics, but the forward PE of 16.1x suggests the market is not pricing a robust recovery, leaving the stock fairly valued at current levels with a value tilt.
Sign up to view all
MOS 12-Month Price Forecast
Mosaic presents a classic cyclical value opportunity with significant uncertainty. The stock is deeply discounted on asset-based metrics, and the recent supply disruption has provided a catalyst for a rally, but the company's Q1 2026 loss and negative free cash flow highlight the fragility of its earnings. The analyst consensus is moderately bullish, but the wide target range and mixed institutional ratings reflect genuine debate about whether the fertilizer cycle has bottomed. I would upgrade to bullish if gross margins recover above 15% and free cash flow turns positive, and downgrade to bearish if the dividend is cut or if the stock breaks below $19.80. At current levels, the risk/reward is balanced, favoring a neutral stance until clearer signs of a sustainable recovery emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $26.77 and implied upside of +9.4% versus the current price.
Average Target
$26.77
0 analysts
Implied Upside
+9.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$17 - $35
Analyst target range
Mosaic is covered by 18 analysts with a consensus recommendation of "buy" and a recommendation mean of 2.45 (where 1.0 is Strong Buy and 5.0 is Strong Sell), indicating a moderately bullish tilt. The average target price of $26.77 implies approximately 6.3% upside from the current price of $25.19, a relatively modest expected return that suggests analysts see the stock as fairly valued after the recent rally. The consensus EPS estimate of $2.82 for the forward period represents a dramatic improvement from the trailing EPS of $0.07, and the estimated revenue average of $11.9 billion implies roughly flat to modest growth from current run-rate levels. The buy consensus is notable given the recent Q1 loss, suggesting analysts are looking through the trough and expecting meaningful margin recovery driven by the fertilizer supply disruptions. The target price range is wide, spanning from a low of $17.00 to a high of $35.00 — a 106% spread between the extremes — which signals significant disagreement about the company's earnings trajectory. The high target of $35.00 (39% above current price) likely assumes successful margin recovery, phosphate and potash price appreciation from supply disruptions, and a return to the $1.29+ quarterly EPS levels seen in mid-2025, while the low target of $17.00 (32.5% below current price) prices in continued margin compression, potential dividend cuts, and a prolonged fertilizer downcycle. Institutional ratings show a mixed but recently improving pattern: RBC Capital upgraded to Outperform from Sector Perform in May 2026, Freedom Broker upgraded to Buy from Sell in June 2026, and BMO Capital maintained Outperform, while JP Morgan has held an Underweight rating and Morgan Stanley, Barclays, Wells Fargo, UBS, and Mizuho remain Neutral or Equal Weight. The presence of both upgrades and persistent bearish ratings from major banks suggests the investment community is in the early stages of reassessing the fertilizer cycle, with the wide target spread reflecting genuine uncertainty about whether the recent supply disruptions represent a durable inflection point or a temporary spike.
Drowning in data?
Find the real signal!
Bulls vs Bears: MOS Investment Factors
The bear case currently has stronger evidence, anchored by the Q1 2026 net loss of $257.6 million, negative free cash flow of -$489.3 million, and a forward PE that exceeds the trailing PE, implying expected earnings deterioration. However, the bull case is gaining traction: the stock has rallied 11.5% in the past month, outperforming the S&P 500 by 12.5 percentage points, driven by the Hormuz supply shock that disproportionately benefits North American producers. The most important tension is whether the fertilizer supply disruption represents a durable inflection point or a temporary spike; if phosphate and potash prices sustain their recent firmness, Mosaic's earnings could recover sharply, but if structural oversupply persists, the dividend and balance sheet could come under further pressure. Analyst sentiment is split, with a consensus 'buy' but a wide target range of $17 to $35, reflecting genuine uncertainty. The resolution of this debate will likely hinge on the next two quarters of margin performance and the sustainability of fertilizer prices.
Bullish
- Deep Value on Book and Sales: MOS trades at just 0.63x book value and 0.63x sales, roughly 90% below its 2022 peak multiples of 2.09x P/B and 6.21x P/S. This extreme compression suggests the market has priced in a permanent impairment of earnings power, leaving substantial re-rating potential if fertilizer fundamentals normalize.
- Supply Shock from Hormuz Closure: The Strait of Hormuz closure has stranded a third of global fertilizer supply, disproportionately benefiting North American producers with domestic inputs. Mosaic's phosphate rock mines in Florida and Louisiana and potash mines in Saskatchewan position it as a direct beneficiary of this supply disruption.
- Revenue Growth Despite Margin Pain: Q1 2026 revenue of $2.998 billion grew 14.4% year-over-year, showing volume and pricing resilience even as gross margin compressed to 7.9%. The top-line growth indicates underlying demand remains firm, and any margin recovery would flow disproportionately to earnings.
- Analyst Consensus Buy with Upside: 18 analysts have a consensus 'buy' rating with a mean of 2.45 and an average target price of $26.77, implying 6.3% upside from $25.19. The high target of $35.00 (39% upside) reflects a credible recovery scenario, and recent upgrades from RBC and Freedom Broker suggest sentiment is turning.
Bearish
- Q1 2026 Swing to $257.6M Loss: Mosaic reported a net loss of $257.6 million in Q1 2026, a $496 million swing from the $238.1 million profit in Q1 2025. Gross margin collapsed to 7.9% from 18.6%, and operating income turned negative at -$372.9 million, highlighting severe earnings deterioration.
- Negative Free Cash Flow and Dividend Risk: Trailing twelve-month free cash flow is -$489.3 million, with Q1 2026 operating cash flow of only $104.2 million against $356.8 million in capital expenditures. The company paid $70.8 million in dividends during the quarter, a 51.9% payout ratio that appears unsustainable against current cash generation, raising the risk of a dividend cut.
- Forward PE Exceeds Trailing PE: The forward PE of 16.1x is higher than the trailing PE of 14.2x, an unusual inversion that implies the market expects earnings to decline from trailing levels. This is consistent with the Q1 loss dragging down forward estimates, and it suggests the stock is not as cheap as the trailing multiple implies.
- Wide Analyst Target Spread Signals Uncertainty: The target price range spans from $17.00 to $35.00, a 106% spread, indicating deep disagreement about the earnings trajectory. JP Morgan maintains an Underweight rating, and several major banks remain Neutral, reflecting skepticism that the recent supply disruptions represent a durable inflection point.
MOS Technical Analysis
Mosaic is in a recovery phase within a broader downtrend, with the stock down 25.2% over the past year but up 11.5% in the last month and 11.0% over three months. At $25.19, the stock trades at just 30.3% of its 52-week range (low of $19.80, high of $36.99), having recovered 27.2% from the 52-week low but still sitting 31.9% below the 52-week high. This positioning suggests the market is pricing a cyclical trough recovery rather than momentum-driven overextension, though the stock remains deeply discounted relative to where it traded a year ago. The 180-day price series shows a clear bottoming pattern: the stock declined from $27.67 in mid-March to a trough of $19.82 on June 10, then established a higher-low structure with a secondary dip to $20.65 on July 8 before rallying to the current $25.19. The 1-month gain of 11.5% is particularly notable against the S&P 500's -1.1% decline over the same period, producing a relative strength of +12.5 percentage points — a sharp positive divergence that suggests idiosyncratic, fertilizer-specific catalysts are driving the move rather than broad market beta. The 3-month relative strength of +8.0 points confirms this outperformance is not a one-month anomaly, though the 1-year relative strength of -41.4 points underscores how much ground remains to be recovered. Key technical resistance sits at the $27.67 March swing high, with the 52-week high of $36.99 representing the longer-term ceiling; support is anchored at the $19.80-$19.82 double-bottom zone, and a breakdown below that level would signal a resumption of the primary downtrend. With a beta of 0.831, Mosaic is roughly 17% less volatile than the broader market, which is unusual for a commodity producer and suggests the stock's recent 11% monthly move is driven by company-specific fundamentals rather than leveraged market exposure — a favorable dynamic for risk-adjusted position sizing. The maximum drawdown of -44.8% over the period illustrates the severity of the prior decline and the magnitude of the recovery trade now underway.
Beta
0.83
0.83x market volatility
Max Drawdown
-44.8%
Largest decline past year
52-Week Range
$20-$37
Price range past year
Annual Return
-28.5%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | +10.1% | -1.0% |
| 3m | +6.9% | +2.0% |
| 6m | +3.8% | +17.4% |
| 1y | -28.5% | +15.0% |
| ytd | -2.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Mosaic's revenue trajectory is showing resilience despite profitability challenges, with Q1 2026 revenue of $2.998 billion representing 14.4% year-over-year growth from Q1 2025's $2.621 billion. However, the multi-quarter trend reveals significant volatility: revenue peaked at $3.452 billion in Q3 2025 before declining to $2.603 billion in Q4 2025 and recovering to $2.998 billion in Q1 2026. Segment data shows Phosphates as the largest contributor at $1.426 billion, followed by Mosaic Fertilizantes at $937.1 million and Potash at $671.4 million, indicating that the phosphate business remains the primary revenue engine while the Brazilian distribution segment provides geographic diversification. The 14.4% YoY growth is encouraging, but the sequential decline from Q3 2025's peak suggests pricing and volume headwinds persist, making the sustainability of the current growth rate the central question for the investment case. Profitability has deteriorated sharply, with Q1 2026 net income of -$257.6 million compared to +$238.1 million in Q1 2025, a swing of nearly $496 million, while gross margin compressed to 7.9% from 18.6% a year earlier. The trailing twelve-month gross margin of 15.1% and operating margin of 8.7% mask the severity of the recent compression, and the Q1 2026 operating loss of -$372.9 million reflects both margin compression and $472.6 million in other expenses. The net margin of 4.5% on a trailing basis is thin for a commodity producer, and the quarterly EPS of -$0.79 contrasts starkly with the $0.75 earned in Q1 2025, highlighting the earnings volatility inherent in the fertilizer cycle. Mosaic's balance sheet remains a relative strength, with a debt-to-equity ratio of 0.437 and a current ratio of 1.315 providing adequate liquidity, though the trailing twelve-month free cash flow of -$489.3 million is a significant concern. Q1 2026 operating cash flow was only $104.2 million against capital expenditures of $356.8 million, producing negative free cash flow of -$252.6 million, and the company paid $70.8 million in dividends during the quarter — a payout ratio of 51.9% that appears unsustainable against current cash generation. With ROE of just 4.5% and ROA of 1.2%, the company is not generating sufficient returns on its asset base, and the negative FCF means growth investments are being funded through a combination of cash reserves ($299 million at quarter-end) and debt, raising questions about the durability of the 3.67% dividend yield if the margin environment does not improve.
Quarterly Revenue
$3.0B
2026-03
Revenue YoY Growth
+14.4%
YoY Comparison
Gross Margin
7.9%
Latest Quarter
Free Cash Flow
$-489300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
With trailing net income positive on a TTM basis (EPS of $0.07), the PE ratio is the appropriate primary metric, and Mosaic trades at a trailing PE of 14.2x versus a forward PE of 16.1x — an unusual inversion where the forward multiple exceeds the trailing multiple. This implies the market expects earnings to decline from trailing levels, consistent with the Q1 2026 loss dragging down forward estimates, though the forward PE is calculated on estimated EPS of $2.82 which would represent a substantial recovery from current run-rate profitability. The PEG ratio of 0.068 is exceptionally low, suggesting that if the estimated growth materializes, the stock is dramatically undervalued relative to its growth rate, though this metric is unreliable when the earnings base is near zero. On a price-to-book basis, MOS trades at 0.63x — a deep discount to book value — and the price-to-sales ratio of 0.63x is similarly depressed, while the EV/EBITDA of 4.84x is well below the broader market and reflects the market's skepticism about normalized earnings power. Comparing Mosaic's valuation to the Agricultural Inputs industry, the stock trades at a significant discount across most metrics: the 0.63x P/B and 0.63x P/S are well below typical sector levels, and the 14.2x trailing PE is moderate but the 16.1x forward PE suggests the market is not pricing in a robust recovery. The 4.84x EV/EBITDA is particularly notable — for a capital-intensive commodity producer with $96 million in quarterly EBITDA, this multiple implies the market values the enterprise at less than 5x current EBITDA, a level typically associated with deep cyclical troughs or structural concerns about asset quality. The dividend yield of 3.67% provides a meaningful income component that partially compensates for the earnings uncertainty, though the 51.9% payout ratio raises sustainability questions. Historically, Mosaic's valuation has compressed dramatically from its 2022 peak levels: the P/B ratio has fallen from 2.09x in Q1 2022 to 0.63x currently, and the P/S ratio has declined from 6.21x to 0.63x over the same period, representing a roughly 90% compression in both metrics. The trailing PE has ranged from 4.1x in Q2 2022 to negative territory in loss quarters, and the current 14.2x sits in the middle of that historical band but on a much lower earnings base. The stock is trading near the bottom of its own historical valuation range on P/B and P/S, which could signal either a deep value opportunity if fertilizer fundamentals normalize or a value trap if structural oversupply persists — the market is clearly pricing in the latter scenario, and the recent 11% rally suggests some investors are beginning to bet on the former.
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Mosaic faces significant financial and operational risks, primarily stemming from its negative free cash flow of -$489.3 million on a trailing twelve-month basis. Q1 2026 operating cash flow was only $104.2 million against capital expenditures of $356.8 million, producing a free cash flow deficit of -$252.6 million, while the company paid $70.8 million in dividends during the quarter. This 51.9% payout ratio is unsustainable against current cash generation, and with only $299 million in cash reserves at quarter-end, the company may be forced to cut the dividend or increase debt to fund operations. Additionally, the sharp swing from $238.1 million net income in Q1 2025 to a $257.6 million net loss in Q1 2026 highlights extreme earnings volatility, and the 7.9% gross margin is well below the trailing twelve-month average of 15.1%, indicating that profitability remains under severe pressure. The debt-to-equity ratio of 0.437 and current ratio of 1.315 provide some cushion, but the negative FCF means growth investments are being funded through cash reserves and debt, raising questions about the durability of the 3.67% dividend yield if the margin environment does not improve.
Market and competitive risks are equally pronounced, with valuation compression risk if the stock's recent rally proves unsustainable. MOS trades at a forward PE of 16.1x, which is above the trailing PE of 14.2x, implying the market expects earnings to decline; if forward estimates are revised lower, the stock could face multiple compression. The beta of 0.831 indicates lower volatility than the broader market, but the stock's 1-year relative strength of -41.4 percentage points underscores how much it has lagged, and a sector rotation away from materials could exacerbate downside. Competitive disruption from new global fertilizer capacity, particularly from low-cost producers in the Middle East and North Africa, could pressure prices even as the Hormuz closure temporarily disrupts supply. Regulatory headwinds, such as environmental regulations on phosphate mining in Florida, could increase operating costs, and the company's significant exposure to Brazilian agricultural demand through Mosaic Fertilizantes adds currency and political risk. Recent news of the Hormuz closure has boosted fertilizer stocks, but if the disruption resolves quickly, prices could normalize and erase recent gains.
The worst-case scenario for Mosaic would be a combination of a rapid resolution to the Hormuz supply disruption, a resumption of structural oversupply, and a dividend cut, leading to a sharp sell-off. In this scenario, the stock could retest its 52-week low of $19.80, representing a 21.4% decline from the current price of $25.19, or fall to the analyst low target of $17.00, a 32.5% decline. The maximum drawdown over the past 180 days was -44.8%, illustrating the severity of prior declines, and a breakdown below the $19.80-$19.82 double-bottom support zone would signal a resumption of the primary downtrend. If fertilizer prices collapse and the company reports another quarterly loss, the stock could lose a third of its value, and the dividend yield of 3.67% would likely be cut, further pressuring the shares. Investors could lose 21% to 33% from current levels in this adverse scenario, with the downside amplified if broader market conditions deteriorate.
FAQ
The most severe risk is financial: Mosaic has negative trailing twelve-month free cash flow of -$489.3 million, and its 51.9% dividend payout ratio is unsustainable against current cash generation, raising the possibility of a dividend cut. Second, operational risk: the company's Q1 2026 net loss of $257.6 million and 7.9% gross margin show extreme earnings volatility, and a failure to recover margins could lead to further losses. Third, market and competitive risk: the recent rally is tied to the Hormuz supply disruption, and a quick resolution could cause fertilizer prices to normalize, erasing gains. Additionally, structural oversupply from global capacity expansions could keep prices depressed. Fourth, macro risk: with a beta of 0.831, MOS is less volatile than the market, but a strong dollar or weak Brazilian agricultural demand could hurt results. These risks are ranked from most to least severe, with the dividend cut being the most immediate concern.
Our 12-month forecast for MOS includes three scenarios. The base case (50% probability) targets $25-$28, assuming stable fertilizer prices and gradual margin recovery, aligning with the analyst average target of $26.77. The bull case (25% probability) targets $32-$35, driven by sustained supply disruptions and margin expansion above 15%, reaching the analyst high target of $35.00. The bear case (25% probability) targets $17-$20, assuming a quick resolution to the Hormuz closure, continued margin compression, and a dividend cut, aligning with the 52-week low of $19.80 and analyst low target of $17.00. The most likely scenario is the base case, which assumes no dramatic change in fertilizer fundamentals but modest improvement from the Q1 trough. Key to this forecast is the sustainability of phosphate and potash prices and the company's ability to generate positive free cash flow.
MOS appears undervalued on asset-based metrics but fairly valued on earnings-based metrics. The price-to-book ratio of 0.63x and price-to-sales ratio of 0.63x are near historic lows, roughly 90% below their 2022 peaks, suggesting the market has priced in a permanent downcycle. The EV/EBITDA of 4.84x is also well below typical sector levels of 8-10x. However, the forward PE of 16.1x exceeds the trailing PE of 14.2x, implying the market expects earnings to decline, and the PEG ratio of 0.068 is unreliable due to the near-zero earnings base. Compared to peers, MOS trades at a discount, but the discount may be justified by its negative free cash flow and high dividend payout ratio. The market is pricing in a prolonged period of weak profitability, so any recovery could trigger a re-rating.
Whether MOS is a good buy depends on your risk tolerance and time horizon. The stock trades at a deep discount to book value (0.63x P/B) and sales (0.63x P/S), and the analyst consensus target of $26.77 implies 6.3% upside, with the high target of $35.00 offering 39% potential. However, the company reported a $257.6 million net loss in Q1 2026 and has negative free cash flow of -$489.3 million, raising concerns about dividend sustainability. The recent 11.5% rally has been driven by the Hormuz supply disruption, which may be temporary. For value investors with a high risk tolerance and a 2-3 year horizon, MOS could be a good contrarian buy if fertilizer prices recover. For conservative investors, the risks outweigh the rewards at current levels.
MOS is more suitable for long-term investment than short-term trading, but it requires a high risk tolerance and a 2-3 year horizon. The stock is in a cyclical trough, and the recovery may take time to materialize; the beta of 0.831 indicates lower volatility than the market, but the maximum drawdown of -44.8% over the past 180 days shows it can still experience sharp declines. The dividend yield of 3.67% provides some compensation for holding, but the payout ratio of 51.9% is at risk if earnings do not recover. Short-term traders might capitalize on the recent momentum, but the wide analyst target range and binary nature of the fertilizer supply situation make timing difficult. For long-term investors, the deep discount to book value and essential role in global food security offer a margin of safety, but position sizing should be conservative given the financial risks. A minimum holding period of 18-24 months is suggested to allow for a full cyclical recovery.
